He added that overall he is very pleased with the growth the company saw in China over the past few years, but far from satisfied.
Johnson & Johnson has been in the Chinese mainland for more than 30 years, where it employs almost 9,000 people.
Despite some multinational companies shifting manufacturing plants away from China to seek lower costs, Gorsky said Johnson & Johnson will keep expanding its manufacturing presence in the country.
"We continue to see real opportunities and we're actually expanding our manufacturing capacity in China," Gorsky said.
"We made investments in local infrastructure. Many of our products are high-tech products, requiring unique skills and capabilities. That provides a advantage in the market place."
As for the healthcare market, China's western region has more opportunities because of its higher growth.
The real opportunity in the western part of the country is the company's partnership in this area to help develop skills, clinics and to better eradicate diseases with new compounds, according to Gorsky.
1 killed in SW China helicopter crash
Feedback
RSS
